Metabolic diseases such as obesity and its severe complication, type 2 diabetes, are associated with insulin resistance where the AKT signaling pathway is impaired, leading to abnormal glucose metabolism in insulin-responsive tissues including BAT, WAT, and skeletal muscles. This evidence concerns the gene AKT1 and metabolic disease.